STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Monthly information on share capital and company voting rights

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags

Cellectis (CLLS) published its monthly information on share capital and voting rights as of November 30, 2025. The release reports the total number of shares as 100,325,454 and the total number of voting rights as 105,406,812. The announcement lists the listing market as Euronext Growth and the ISIN code as FR0010425595. Contact details for media and investor relations are provided for further information.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

(Article 223-16 of General Regulation of the French financial markets authority)

PARIS, Dec. 03, 2025 (GLOBE NEWSWIRE) --

Listing market: Euronext Growth

ISIN code: FR0010425595

DateTotal number of shares
in the capital
Total number of voting rights
11/30/2025100,325,454105,406,812

For further information on Cellectis, please contact:     

Media contacts:
Pascalyne Wilson, Director, Communications, +33 (0)7 76 99 14 33, media@cellectis.com
Patricia Sosa Navarro, Chief of Staff to the CEO, +33 (0)7 76 77 46 93

Investor Relations contact:
Arthur Stril, Chief Financial Officer & Chief Business Officer, investors@cellectis.com

Attachment


FAQ

What number of shares did Cellectis (CLLS) report on November 30, 2025?

Cellectis reported a total of 100,325,454 shares as of 11/30/2025.

How many voting rights does Cellectis (CLLS) have as of November 30, 2025?

The total number of voting rights was reported as 105,406,812 on 11/30/2025.

Where is Cellectis (CLLS) listed and what is its ISIN code?

Cellectis is listed on Euronext Growth and its ISIN is FR0010425595.

When is the reporting date for the share capital and voting rights figures for Cellectis (CLLS)?

The figures are reported with an effective date of November 30, 2025.

Who can investors contact for more information about Cellectis (CLLS) share capital?

Investor relations contact is Arthur Stril, Chief Financial Officer & Chief Business Officer at investors@cellectis.com.

Where can I find the voting rights attachment for Cellectis (CLLS) November 2025?

The announcement references an attachment titled Voting_Rights_PR_November_2025_EN for detailed information.
Cellectis

NASDAQ:CLLS

CLLS Rankings

CLLS Latest News

CLLS Latest SEC Filings

CLLS Stock Data

468.52M
72.33M
3.85%
18.77%
0.21%
Biotechnology
Healthcare
Link
France
Paris